These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Localized delivery of anti-cancer drugs by electroporation. Featherstone C Mol Med Today; 1998 Feb; 4(2):47. PubMed ID: 9547785 [No Abstract] [Full Text] [Related]
7. [Recent proposals for early stage clinical trials of cancer]. Ohashi Y Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():292-4. PubMed ID: 7986106 [TBL] [Abstract][Full Text] [Related]
8. [Results of the clinical study of the antineoplastic preparation phenamet]. Lichinitser MR; Garin AM; Blokhina NG; Vaarik KhM; Voznyĭ EK Vopr Onkol; 1974; 20(5):91-2. PubMed ID: 4612985 [No Abstract] [Full Text] [Related]
9. Implications of dose intensity for cancer clinical trials. Semin Oncol; 1987 Dec; 14(4 Suppl 4):1-44. PubMed ID: 3686043 [No Abstract] [Full Text] [Related]
10. Clinical cancer chronotherapy trials: a review. Bjarnason GA J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175 [TBL] [Abstract][Full Text] [Related]
11. Progression-free survival remains debatable endpoint in cancer trials. Tuma R J Natl Cancer Inst; 2009 Nov; 101(21):1439-41. PubMed ID: 19828873 [No Abstract] [Full Text] [Related]
12. Cancer treatment and the older patient. Trimble EL; Christian MC Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1956-7. PubMed ID: 16609002 [No Abstract] [Full Text] [Related]